🡄 back

Turnstone Biologics
Driving The Power of Innate and Adaptive Tumor Immunity

Turnstone Biologics is focused on driving innate and adaptive tumor immunity through the development of two independent, yet complementary platforms, built on a foundation of validated clinical success.

Turnstone Biologics is a privately-held clinical stage biotech company with offices and facilities in New York, Ottawa and Hamilton. Turnstone’s proprietary vaccinia virus platform is engineered to drive coordinated immune activation, potent viral activity plus local expression of encoded therapeutics, while the TIL cell therapy platform leverages clinically validated protocols to add industry-leading cell selection strategies. Our development programs drive innate and adaptive tumor immunity to provide benefit to the millions of cancer patients underserved by current treatment options.

Fast Facts
Contact Email: [email protected]
Are you hoping to connect with this partner? Fill out our form below and we can reach out to you to find the best way to connect you.